Tech Company Financing Transactions

DalCor Pharmaceuticals Funding Round

DalCor Pharmaceuticals, based in Sarasota, secured $150 million in investment from private investors, Sanderling Ventures and CDC - Caisse des Depots.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Series B
Proceeds Purpose
DalCor will use the proceeds to fund a Phase 3 clinical trial of dalcetrapib, a CETP inhibitor, in patients who have recently experienced Acute Coronary Syndrome (ACS).

Company Information

Company Status
Private & Independent
Mailing Address
677 N. Washington Blvd. 32
Sarasota, FL 34236
Email Address
DalCor is focused on providing precision medicine through identification of genetically distinct patient populations that derive clinical benefits. By integrating clinical, biologic and genetic insights, DalCor intends to deliver superior outcomes in clinical medicine.
DalCor Pharmaceuticals LinkedIn Company Profile
Social Media
DalCor Pharmaceuticals Company Twitter Account
Company News
DalCor Pharmaceuticals News
DalCor Pharmaceuticals on Facebook
DalCor Pharmaceuticals on YouTube

Management Team

Email & Social
Chief Executive Officer
Fouzia Laghrissi-Thode
  Fouzia Laghrissi-Thode LinkedIn Profile  Fouzia Laghrissi-Thode Twitter Account  Fouzia Laghrissi-Thode News  Fouzia Laghrissi-Thode on Facebook
Chief Financial Officer
Michael Dixon
  Michael Dixon LinkedIn Profile  Michael Dixon Twitter Account  Michael Dixon News  Michael Dixon on Facebook
Chief Medical Officer
Donald Black
  Donald Black LinkedIn Profile  Donald Black Twitter Account  Donald Black News  Donald Black on Facebook
VP - Operations
Therese Heinonen
  Therese Heinonen LinkedIn Profile  Therese Heinonen Twitter Account  Therese Heinonen News  Therese Heinonen on Facebook
VP - Operations
Peter Schuepbach
  Peter Schuepbach LinkedIn Profile  Peter Schuepbach Twitter Account  Peter Schuepbach News  Peter Schuepbach on Facebook



Browse more venture capital transactions:

Prev: 4/20/2016: TrapX Security venture capital transaction
Next: 4/20/2016: PicsArt venture capital transaction


Share this article


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary